[Form 4] Yum China Holdings, Inc. Insider Trading Activity
Yum China Holdings insider grant details: Adrian Ding, identified as Chief Financial Officer and a director, reported acquisitions of Restricted Stock Units (RSUs) on 09/23/2025. The Form 4 shows six separate RSU accruals totaling 170 RSUs received as dividend-equivalency payments tied to previously issued RSUs and issued at a $0 price. Each tranche vests on the same schedule as the underlying awards (various schedules: annual 1/4 vesting, 50%/50% on years two and three, or 1/3 per year), and the newly reported units convert one-for-one into common shares with no expiration. The report was signed under power of attorney on 09/25/2025.
- 170 RSUs granted to the CFO as dividend-equivalency payments, aligning executive compensation with shareholders
- Grants issued at $0 reflect non-cash compensation rather than insider sales or cash transactions
- Vesting tied to underlying awards, preserving original incentive alignment and performance timelines
- None.
Insights
TL;DR: Routine, non-cash grant increases insider alignment with shareholders but is likely compensation not market-moving.
The Form 4 documents 170 RSUs issued to the CFO as dividend-equivalency payments at a $0 price, converting one-for-one into common stock when vested. These units follow the vesting schedules of prior awards, indicating these are supplemental, not new performance grants. For modeling or dilution analysis, treat these as potential future share issuance if and when they vest and convert, but the filing contains no cash proceeds, sales, or change in control events.
TL;DR: Governance-wise this is a routine disclosure of compensation-related RSUs with clear vesting alignment to original awards.
The reporting person is the CFO and a director, and the units are described as dividend-equivalency RSUs that vest on the same terms as underlying awards (annual or multi-year schedules). The filing discloses direct beneficial ownership increases across multiple award tranches and includes a Power of Attorney signature, satisfying procedural requirements. No departures, option exercises, or disposals are reported.